FibroGen (FGEN) Tops Q4 EPS by 35c

FibroGen (NASDAQ: FGEN) reported Q4 EPS of $0.18, $0.35 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $22.09 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Chemours reaches $450M settlement over PFAS pollution at four sites
• GraniteShares 2x Long PLTR Daily ETF (PTIR) call put ratio 5.7 calls to 1 put with a focus on July 10 calls
• SpaceX (SPCX) call put ratio 1.5 calls to 1.1 puts as share price at $158